New Delhi, 18th October 2024: Mumbai-based ENTOD Pharmaceuticals has appointed Mr. Dharmesh Kharwar as a non-executive independent director on its board. Mr. Kharwar brings with him a remarkable career, having held key positions at FDC Ltd, Johnson & Johnson (J&J), and MSD/Merck. He currently also serves on the boards of both listed and private companies. His diverse experience spans development, manufacturing, regulatory affairs, quality assurance, business development, intellectual property protection, and commercial leadership across the chemical and biologics sectors.
With a strong history of driving innovation and growth, Mr. Kharwar has led large-scale projects, established international collaborations, and significantly contributed to the advancement of both chemical and biological therapeutics. His deep understanding of regulatory frameworks and market strategies makes him a valuable addition to ENTOD Pharmaceuticals.
Commenting on his appointment, Mr. Kharwar said, “I am honored to join ENTOD Pharmaceuticals, a company that places a strong emphasis on being patient- and physician-centric. This focus has fueled its groundbreaking innovations for nearly five decades, and I am excited to contribute to its continued success.”
ENTOD’s CEO, Nikkhil K Masurkar said “I am confident that Mr. Kharwar’s expertise and leadership will further strengthen our mission of delivering world-class cost-effective pharmaceutical solutions and raising the bar when it comes to research & innovation”
Entod Pharmaceuticals is a 47 year old company specialized in Research and development of ENT, Ophthalmology and dermatology sector with an impressive portfolio comprising over 250 products while working in various R&D branches.